SCHEMBL5951501

SCHEMBL5951501

CC1Cc2c(cccc2-c2ccc(C(F)(F)F)cc2C(F)(F)F)C1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 5/20 0.49
EDNRB P24530 1/20 0.42
EDNRA P25101 1/20 0.42
METAP1 P53582 1/20 0.41
KDR P35968 2/20 0.36
PLK4 O00444 1/20 0.36
ROCK2 O75116 1/20 0.36
NTRK1 P04629 1/20 0.36
MET P08581 1/20 0.36
ROS1 P08922 1/20 0.36
RPS6KB1 P23443 1/20 0.36
EPHA2 P29317 1/20 0.36
AXL P30530 1/20 0.36
FLT4 P35916 1/20 0.36
FLT3 P36888 1/20 0.36
FRK P42685 1/20 0.36
MAPK9 P45984 1/20 0.36
IRAK1 P51617 1/20 0.36
ROCK1 Q13464 1/20 0.36
NTRK2 Q16620 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5952403 0.82 ACHE (0.43) ACHEEDNRBEDNRAMETAP1CYP26A1
SCHEMBL5952547 0.81 HTR1A (0.52) ACHEHTR1AHTR7MAOB
SCHEMBL5951885 0.81 ACHE (0.54) ACHEMETAP1KDRHTR1AHTR7
SCHEMBL5951965 0.80 ACHE (0.53) ACHEMETAP1HTR1AHTR7MAOA
SCHEMBL29620987 0.74 ACHE (0.51) ACHECYP26A1TDP2
SCHEMBL5951167 0.72 ACHE (0.55) ACHEHTR1AHTR7
SCHEMBL5952536 0.72 ACHE (0.57) ACHE
SCHEMBL21132327 0.71 ACHE (0.63) ACHETDP2
SCHEMBL28676412 0.71 TSHR (0.56) EDNRBEDNRACRHR1CES2GPR3
SCHEMBL5952071 0.71 ACHE (0.55) ACHEMAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7038070-B2 Preparation of preparing substituted indanones BASELL POLYOLEFINE GMBH (DE) 2006-05-02 US disclosed
US-6963017-B2 Preparation of preparing substituted indanones BASELL POLYOLEFINE GMBH (DE) 2005-11-08 US disclosed
EP-0968158-B1 METHOD OF PREPARING SUBSTITUTED INDANONES, THE SUBSTITUTED INDANONES AND METALLOCENES PREPARED THEREFROM BASELL POLYOLEFINE GMBH (DE) 2005-08-10 EP disclosed
US-20050033076-A1 Preparation of preparing substituted indanones EQUISTAR CHEMICALS, LP 2005-02-10 US disclosed
US-20030009046-A1 Preparation of preparing substituted indanones EQUISTAR CHEMICALS, LP 2003-01-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050033076-A1 Preparation of preparing substituted indanones CYP1A2, CYP2J2, IDH3A ACHE 839/4885EDNRB 1913/4885EDNRA 2350/4885
US-20030009046-A1 Preparation of preparing substituted indanones CYP1A2, CYP1B1, CYP1A1 ACHE 820/4885EDNRB 2088/4885EDNRA 2351/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.